Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor ComparisonRaynier Devillier, Faezeh Legrand, Jérôme Rey, et al.American Journal of Hematology|October 11, 2013
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donorRaynier Devillier, Sabine Fürst, Roberto Crocchiolo, et al.Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.Bulletin Du Cancer|July 13, 2021
[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Marie Thérèse Rubio, Pauline Varlet, Vincent Allain, et al.Bone Marrow Transplantation|November 4, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndromeSamia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 PatientsThomas Pagliardini, Lucas Castagna, Samia Harbi, et al.Blood Advances|April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphomaChiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.Pageof 4